29 Februar 2024 12:59 PM Eastern Daylight Time

BUSINESS WIRE

Aiosyn führt über seine NephroPath-Plattform Nierenbildanalyse-Dienste ein, um Studien zur Medikamentenentwicklung zu beschleunigen

In voller Größe anschauen

Opens in new window

Download-Formate

Volle Größe JPEG, 4768x3016, 628.1 KB
Klein JPEG, 480x304, 38.1 KB
Vorschau im JPEG-Format JPEG, 144x91, 7.2 KB
Kleinbild im JPEG-Format JPEG, 111x70, 4.7 KB

Smart Multimedia-Galerie

Figure 1. Illustration of the NephroPath platform’s capabilities in performing automated quantification and multi-class prediction on an entire rat kidney cortex. Notable classes: normal tubuli (orange), atrophic/dilated tubuli (green/red), glomeruli (pink), abnormal/sclerotic glomeruli (dark blue), arteries (light blue), interstitium (not colored). (Photo: Business Wire)

Figure 1. Illustration of the NephroPath platform’s capabilities in performing automated quantification and multi-class prediction on an entire rat kidney cortex. Notable classes: normal tubuli (orange), atrophic/dilated tubuli (green/red), glomeruli (pink), abnormal/sclerotic glomeruli (dark blue), arteries (light blue), interstitium (not colored). (Photo: Business Wire)

View and Share Foto

http://www.businesswire.de/multimedia/de/20240228483622/de/5606764/

Share

E-Mail

Alle Nachrichten | Nachrichten mit Fotos & Multimedia > Pressemitteilung: Aiosyn führt über seine NephroPath-Plattform Ni...

Weitere Business Wire-Websites